Cargando…
Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
At the clinical level the role of immunotherapy in cancer is currently at a pivotal point. Therapies such as checkpoint inhibitors are being approved at many levels in cancers such as non-small cell lung cancer (NSCLC). Mesothelioma is a rare orphan disease associated with prior exposure to asbestos...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082257/ https://www.ncbi.nlm.nih.gov/pubmed/32206576 http://dx.doi.org/10.21037/tlcr.2019.11.23 |